Development of clinical value unit method for calculating patient costs by Cyganska, Malgorzata et al.
Article
Development of clinical value unit method for 
calculating patient costs
Cyganska, Malgorzata, Cyganski, Piotr and Pyke, Chris
Available at http://clok.uclan.ac.uk/28856/
Cyganska, Malgorzata, Cyganski, Piotr and Pyke, Chris ORCID: 0000­0001­6576­2709 (2019) 
Development of clinical value unit method for calculating patient costs. Health Economics, 28 (8).  
pp. 971­983. ISSN 1057­9230  
It is advisable to refer to the publisher’s version if you intend to cite from the work.
http://dx.doi.org/10.1002/hec.3902
For more information about UCLan’s research in this area go to 
http://www.uclan.ac.uk/researchgroups/ and search for <name of research Group>.
For information about Research generally at UCLan please go to 
http://www.uclan.ac.uk/research/ 
All outputs in CLoK are protected by Intellectual Property Rights law, including
Copyright law.  Copyright, IPR and Moral Rights for the works on this site are retained 
by the individual authors and/or other copyright owners. Terms and conditions for use 
of this material are defined in the http://clok.uclan.ac.uk/policies/
CLoK
Central Lancashire online Knowledge
www.clok.uclan.ac.uk
DEVELOPMENT OF CLINICAL VALUE UNIT METHOD FOR 
CALCULATING PATIENT COSTS 
ABSTRACT 
 
The objective of the study was to develop the Clinical Value Unit method of allocating indirect costs to patient 
costs using clinical factors.  The method was tested to determine whether it is a more reliable alternative to using 
the Length of Stay and Marginal Mark-up allocation method. The method developed used data from a Polish 
specialist hospital.  The study involved 4,026 patients grouped into nine Diagnosis Related Groups (DRG). The 
study methodology involved a three stage approach: (i) identification of correlates of patient costs (ii) a 
comparison of the costs calculated using the Clinical Value Unit method with the alternative methods: Length of 
Stay and Marginal Mark-up methods and (iii) an estimation of the cost homogeneity of the DRGs. The study 
showed that Length of Stay cost allocation method may underestimate the proportion of indirect costs in patient 
costs for a short in-patient stay and overestimate the cost for the patients with a long stay. The total costs 
estimated using the Marginal Mark-up method were higher than those estimated with Length of Stay method. 
For most surgical procedures the mean indirect costs are higher using Clinical Value Unit method than when 
using Length of Stay or Marginal Mark-up method.  In all medical procedure cases the mean indirect costs 
calculated using the Clinical Value Unit method are in the range between Marginal Mark-up and Length of Stay 
method. We also show that in all DRGs except one, that the coefficient of homogeneity for Clinical Value Unit 
is higher than for Length of Stay or Marginal Mark-up method.  We conclude that the Clinical Value Unit 
method of cost allocation is a more precise and reliable alternative than the other methods. 
 
KEY WORDS: costs, hospital, cost allocation, clinical factors, length of stay, activity based 
costing. 
  
1. Introduction  
 
Valid financial management decision making in a hospital requires accurate estimates of 
patient costs. Estimating cost is also important in the assessment for improvement of health 
system performance. Understanding care costs is challenging due to the highly complex, 
fragmented, and variable nature of healthcare delivery. In traditional cost accounting systems 
the most popular cost accounting method is Volume-Based Costing (VBC) (Cao et al., 2006). 
This top-down approach assumes the division of costs into direct and indirect ones (Chapko et 
al., 2008). The direct costs are assigned to inpatients based on the actual resource 
consumption. Direct costs include diagnostics, imaging, laboratory or other diagnostics, 
drugs, and surgery procedures are assigned to a patient using a bottom-up microcosting 
method (Wordsworth et al., 2005). Department indirect costs include those costs incurred by 
medical departments that are not directly related to patients or can not be directly assigned to 
them and are fixed over the short term (Roberts et al., 1999). Kalman et al. (2015) claim that 
depending on the measurement methods, between 30% and 85% of hospital costs can be 
considered non-patient care related. This is consitent with the findings of others, for example 
St-Hilaire et al. (2000) report that indirect costs represent 35%-40% of the total costs of 
hospital services in Canada, Oostenbrink et al. (2002) have estimated 24% of indirect costs in 
the Netherlands hospitals, and Cyganska (2009) reports on 42-60% in Polish hospitals. Most 
published studies present the average cost per hospitalisation or cost per inpatient day 
(Khiaocharoen et al., 2012). Data on the true costs of care for a patient with a particular 
condition are nearly completely absent (Porter, Lee, 2013). An invalid estimation of indirect 
costs may completely wipe out the time and effort spent on the cost determination of direct 
costs. Furthermore, the reliability of accounting information and its usefulness as a tool to 
measure hospital performance depends on the quality and adequacy of the indirect allocation 
method. Under VBC there are three steps involved in allocating hospital costs either to 
individual patients or groups of patient cases which are medically coherent and cost-
homogeneous: (i) the allocation of hospital overhead costs to medical departments; (ii) the 
allocation of department overhead costs to patients; and (iii) the allocation of department 
direct costs to patients. This article will focus on the second and third type of allocation i.e. 
the allocation of indirect costs to patients using key cost drivers. Tan et al., 2011 describe 
three methods for assigning the department costs to patients: (i) Marginal Mark-up precentage 
in which indirect costs are allocated to patients by increasing the direct costs using a mark-up 
percentage, (ii) weighted statistics, like hourly rate allocation or inpatient day allocation, (iii) 
Relative Value Units (RVU) in which the relative costs of each patients are established by 
assigning RVUs. The Marginal Mark-up method is often used by hospitals with a bottom-up 
approach (Tan, Rutten et al., 2009).  Previous studies concluded that Marginal Mark-up 
allocation with a bottom-up approach may be sufficiently accurate for hospital services which 
are not expected to vary widely between patients (Tan, Oppe et al., 2009). The popular 
method of allocating indirect costs to patients is inpatient day allocation (Kludacz-Alessandri, 
2017; Polverejan et al., 2003). It is often used in economic evaluations (Gray et al., 2001; Liu 
et al., 2002). Using this method, the indirect costs are allocated to patients by the length of 
stay and all the patients are assumed to have the same indirect costs per day regardless of their 
actual resource use. Taheri et al. (2000) report that length of stay (LOS) is not a good 
surrogate for costs since not all hospital days are economically equivalent. Analysing 
variations in patient costs it was found that the inpatient costs are associated with LOS, acuity 
of illness, risk of mortality, social status, age, gender, type of admission, destination after 
discharge, Intensive Care Unit (ICU) stay and medical factors (Dahl et al., 2012; Pirson et al., 
2006). Serra-Batlles et al. (1998) report that the progressive increase in the severity of illness 
causes a considerable increase in the total costs. Research conducted by Simrova et al. (2014) 
have revealed that treatment costs significantly differ depending on the selected diagnostic 
and therapeutic procedures. Other researchers (Popesko et al., 2015) highlight differences 
between the costs of individual patients under the same diagnosis and their differing demands 
on hospitals activities. 
The alternative method to Marginal Mark-up and LOS method is the RVU 
methodology. It differentiates the costs, depending on the method of assigning the value base 
units. RVU establishes the relative cost of each patient by assigning a value to the base-line 
resource usage of the hospital service and then adding relative values when the patient uses 
additional resoures. RVUs are a measure of value used to calculate physician reimbursement. 
RVU denotes physician’s time, skill, training and intensity of work going into the production 
of a service (Raval et al., 2010). This method may reflect the case complexity by 
incorporating elements of physicians wages. However, RVU, as a component of a fee 
schedule, might be better turned to capturing aspects relevant to reimbursement rather than to 
estimating costs (Baadh et al., 2016). Moreover, the physician RVU value is determined by a 
subjective physician speciality panel and not by objective measurement of actual resource use 
in practice settings (Goodson, 2007). 
The aformentioned approaches to allocating overhead costs within VBC method are 
easy to use which explains their widespread adoptions. But their ease of use is offset by 
costing inacuracies. In the mid 1990s, a new costing method was introduced to the healthcare 
fields called  Activity Based Costing System (ABC). ABC was claimed to be the alternative 
for volume-based cost accounting systems (Cao et al., 2006). This bottom up approach allows 
the identification of the overhead costs and traces them to each Diagnostic Related Group 
(DRG)/patient based on consumption of activity resources and thus obtain more accurate cost 
data (Chapko et al., 2008, Berlin, Smith, 2004). ABC requires detailed analysis of financial 
accounting records as well as inquires and interviews to identify and gather cost and other 
information on specific activities. ABC is particulary relevant for assessing the costs of 
individual services within complex, integrated healthcare systems like in England or United 
States (Paulus et al., 2002). Developing and implementing ABC in hospitals is very expensive 
and time consuming, which may account for its limited adoption (Udpa, 1996; Cardinaels et 
al., 2004; Emmett, Forget, 2005).  
When deciding on the cost allocation method, one must remember that physicians 
(including clinicians and academic reaserchers) and hospital executives approach the process 
of patient treatment services from two very different perspectives. The physician sees patients 
as primarily involving diagnostic and treatment activities, such as diagnostics test, medical 
procedures. The executive, however, sees the same situation in terms of broader economic 
and accounting context, such as costs versus charges for the entire patient encounter at the 
hospital.  
None of the above methods takes into account clinical parameters in the process of 
allocating hospital costs. Therefore, the purpose of this study was to develop a method of 
allocating indirect costs to patients using patient characteristics, clinical and treatment factors 
and explore the variances of inpatient costs given by Clinical Value Units (CVU) and the 
Length of Stay and the Marginal Mark-up allocation method. In this article, we focus on 
hospital-based treatment approach, and do not address out-of-hospital care, however the 
usefulness of the CVU in ambulatory care will be the subject of future studies.  
 
2. Clinical Value Unit method - conceptual framework 
 
Estimating costs is important in the assessment required to improve the performance of 
healthcare systems, as well as improve management effectiveness in hospitals. The need of 
linking the medical records and cost has been claimed by many authors (Young, Pearlman, 
1993; Cyganska 2018). Although the influence of various patient demographic variables, 
clinical factors and treatment on hospital costs have been widely studied (Uematsu et al., 
2015; Gutacker et al., 2013), sophisticated solutions for using these factors in the allocation of 
overhead costs process have not been developed yet.  
Clinical Value Unit method develops a point scale for measuring patient demographic 
variables, clinical and treatment factors associated with hospital costs. It reflects the 
relationship between these variables and inpatient treatment costs in hospital. This approach 
allows simultaneous comparison of the impact on costs of both quantitative and qualitative 
parameters. 
Assessing the variables of in-hospital costs was previously investigated by standard 
regression model (Polverejan et al., 2003), univariate or multivariate regression analysis 
(Klein et al., 2008) and logistic regression anaylsis (Cyganska, 2017). To identify the 
correlates of costs we propose the logistic regression analysis in which the dependent variable 
is binary, with ‘one’ denoting patient being a cost outlier (CO) and ‘zero’ denoting not cost 
outlier. Cost outliers are identified as patients whose attributes fall outside the Q3+1.5R 
interval, where Q3 is the third quartile and R is the interquartile range (quartile deviation). 
Factors significantly increasing the risk of becoming outlier are identified by logistic 
regression analysis as follows: 
𝑙𝑜𝑔𝑖𝑡 𝑃 = 𝑙𝑛 (
𝑃
1 − 𝑃
) = 𝛽0 + ∑ 𝛽𝑗
𝑛
𝑗=1
𝑥𝑗  
 
where 𝛽 is the regression coefficient, xj is the independent variable for patient j =1, ….,n 
(patient demographic variables, clinical and treatment factors), P is the probability of patient 
becoming cost outlier. To discard the set of independent variables that do not add significantly 
to the fit of the model, backward stepwise regression is used. The beta coefficients of the 
normalized parameters in multiple regression analysis are used to build a Clinical Value Unit 
scale for a qualitative description of patient-related parameters as follows in table 1. The 
developed scale illustrates the correlations between the patient characteristics, health 
condition on admission and hospital treatment vs. patient costs.  
 Tab. 1 
 
The number of points scored by every variable in every category is summed up for every 
patient to produce a synthetic index (CVU). It’s based on the identified variables 
characterizing the patient, the patient’s health condition and hospital treatment and describes 
the cost intensity of treatment as follows:  
𝐶𝑉𝑈𝑗 = ∑ 𝛽𝑖𝑗
𝑚
𝑖=1
 
where CVUj  is the number of Clinical Value Units for patient j =1, ….,n, 𝛽𝑖𝑗 – regression 
coefficient for correlates i =1, ….,m of patient j =1, ….,n. The number of CVUs for all 
patients in the hospital department is expressed as follows: 
𝐶𝑉𝑈 = ∑ 𝐶𝑉𝑈𝑗
𝑛
𝑗=1
 
3. Materials and methods  
 
3.1. Data 
We tested the developed method using data from the Provincial Specialized Hospital in 
Olsztyn, Poland. The hospital provides diagnostics, therapy, care, specialist advice, education, 
prevention, and health promotion. It is the biggest public hospital in the region financed by 
the National Health Fund (NFZ). The hospital has 455 beds, more than 130,000 outpatient 
visits per year and more than 15,000 inpatient admissions per year with occupancy rates about 
80 percent. Between January and June 2016 there were 5,367 patients admitted to the 
Departments of Cardiology, Laryngology, Ophthalmology, Nephrology, ICU, 
Gastroenterology, Orthopedics, Surgery, Neurosurgery, Gynecology, Endocrinology, 
Diabetology and Hematology. We reviewed all of the patients that were admitted to the 
hospital departments during a 6-month period, except newborns (n = 457). Some of the 
patients were excluded from the analysis because of missing data (n = 365). Finally, we have 
included 4,026 patients grouped into nine high volume Diagnosis Related Groups (DRG)* 
(Table 2).  
 
Tab. 2 
The study methodology involved a three stage approach: (i) identification of cost variables 
(ii) a comparison of the estimated costs using the CVU with the LOS and Marginal Mark-up 
methods and (iii) an estimation of the cost homogeneity of the DRGs. Each of these steps is 
explained in details below. 
                                                            
* The Polish Diagnosis Related Group system was introduced in 2003 and is based on the English system called 
Human Recource Group (HRG 3.5 version). 
3.2. Identification of cost allocation factors 
Data were obtained from two computerized databases: administrative and medical. We 
considered age, LOS, gender, type of admission, reason for discharge, Intensive Care Union 
(ICU) stay and the number of departments that the patient was  treated on as the possible 
factors that may influence the hospital costs. Annual direct and overhead costs were taken 
from the annual accounts of the hospital departments. All costs were based on the 2016 cost 
data. Cost in PLN were converted to euro on the basis of average exchange rate of NBP 
(Polish National Bank) from 31.01.2017 (1€ = 4.3308 PLN). We selected a cost allocation 
based on the factors that significantly affect the direct costs of the patients. Using multiple 
regression analysis with a backward stepwise regression method (Johnson et al., 2002). A 
significance level of 0.05 was adopted as the criterion for entering the factors into the 
regression model.  Univariate regression analysis was performed to assess the association 
between direct costs and each of the factors listed above. Statistical analysis was carried out 
using STATISTICA, version 13.3, StatSoft, Inc. (2011). 
 
3.3. The methodologies 
3.3.1. CVU method 
We established the clinical value units for each patient based on the predetermined 
cost allocation factors. We then used multivariate logistic regression analysis to separate the 
relationship between the CO (dependent variable) and treatment characteristics as explanatory 
variables (Tan, Oppe et al., 2009). The β coefficients of the explanatory variables that were 
significantly associated with the CO were assumed as the basis of allocating the overhead 
costs to the individual patients. Each patient was assigned a relative unit. Total CVUs were 
calculated by multiplying the number of variables and its CVU. 
 
3.3.2. Length of stay allocation method 
When we calculated the length of stay allocation, all patients were assumed to have the 
same indirect costs per day regardless of their actual resource usage. The annual indirect costs 
were divided by the total number of inpatient days in 2016 to calculate the unit costs per 
inpatient day. 
 
3.3.3. Marginal Mark-up allocation method 
When we calculated the Marginal Mark-up allocation, indirect costs are distributed to 
the patients by increasing the direct costs with a mark-up percentage, which was determined 
by dividing annual indirect costs by annual direct costs. 
 
3.3.4. A Comparison of methodologies 
In addition to descriptive statistics, Wilcoxon’s signed rank test was used to compare the 
three methods for each DRG. A p-value of less than 0.05 was considered statistically 
significant. The “goodness of fit” in each estimation was analyzed by the coefficient of 
determination. All costs are expressed in Euros. The distribution of continuous data was 
expressed by mean ± standard deviation if appropriate. 
 
3.4. Estimation of the cost homogeneity of DRGs 
To quantify improvements in the cost calculation we used the reduction in the variance of 
costs.  We analyzed cost homogeneity of DRGs using the coefficient of homogeneity (CH). A 
CH of 1 indicates full homogeneity, whereas a CH close to 0 indicates no homogeneity (Vogl, 
2012). 
 
4. Results 
Multivariate logistic regression model results in Table 3 shows that age, gender, LOS, 
ICU stay and the inter-department treatment increase a patient’s probability of being CO. 
 
Tab. 3 
The probability of being CO increased more than 2.5 times with each subsequent day 
of stay in hospital, more than 36% for patients that stayed in ICU, and more than 10% for 
male patients. We used beta coefficients to calculate Clinical Value Units for a qualitative 
description of patient-related parameters. In table 4 we presented the number of points scored 
by each variable summed up for every patient within DRG.  
Tab. 4 
 
The mean CVU reflects that the most cost-consuming, regarding risk factors of being 
CO,  are women classified in N03, and the least cost-consuming are patients from M15.  
We used CVU to allocate overhead costs to patient within DRG. As can be seen in Table 5 for 
N09 the CVU method resulted in indirect costs of €1111.80 (SD 419.97). The proportion of 
direct and indirect cost components to total costs was 41.21% and 58.79% respectively. The 
indirect estimates of LOS method were much higher than the CVU method (€ 1971.76). The 
proportion of indirect cost components was 71.67%. The Marginal Mark-up method resulted 
in overhead cost 43.68% lower from CVU and 68.25% lower from LOS method.  
In all analyzed DRG groups the Marginal Mark-up method resulted in 41-44% proportion of 
indirect costs to total costs. The proportion of indirect costs in total costs ranged from 24.81% 
to 82.27% for LOS method and from 28.30% to 84.65% for CVU method. 
Tab 5 
 
 As can be seen in Table 5 in all cases the difference between CVU method, LOS 
method and Marginal Mark-up method was statistically siginficant. In all DGR Groups but 
one, the mean costs was higher for CVU compared to Marginal Mark-up method. The mean 
cost of treatment for patients with a longer stay in hospital was higher for the LOS method in 
comparison to CVU method. In the case of patients from DRG groups with a shorter stay the 
mean cost for LOS method was lower than for CVU method. 
To quantify improvements in cost calculation methods we analyzed cost homogeneity 
of DRGs using the coefficient of homogeneity (Table 6).  
 
 
Tab 6 
 
We observed that in all DRG Groups but one (N09) the CH was higher for CVU method 
in comparison to LOS and Marginal Mark-up method. The range of CH for Marginal Mark-up 
method was 0.4386-0.8149, for LOS method 0.6235 – 0.7760 and for CVU method 0.6444-
0.8843. 
 
5. Discussion of Results 
 
5.1. A comparison of estimation 
The allocation of indirect costs based on the length of stays is a popular method used in 
healthcare accounting systems (Fattore et al., 2004; Needleman et al., 2006, Behner et al., 
1990). However, conventional hospital cost system can report seriously distorted cost per 
patient when patient care is diverse in terms either level of acuity or amount of care. For 
example patients with short stays but who require extensive nursing suport uses more 
recources than patients who require long stays with minimal nursing attention (Udpa, 1996). 
Our study shows that LOS cost allocation method may underestimate the proportion of 
indirect costs allocated to hospital services for a short inpatient stay (B19, E27) and 
overestimate the cost for long stay patients (N09, N07D, N03). We also revealed that the cost 
of DRG with high average LOS (N09, A48, N03) were twice as high as those using LOS 
method or using the Marginal Mark-up method, which is consistant with Tan, Rutten et. al. 
(2009) findings. The high percentage of cost distribution based on LOS especially influences 
the cost of medical DRGs (conservative therapy) where the fraction of directly case-related 
costs is low compared with operative DRGs. Marginal Mark-up method is used for allocating 
overhead and capital cost in micro-costing approaches (Al et al., 2010).  The difference 
between Marginal Mark-up method and LOS method is not significant in terms of small 
surgery procedures (B19, E 27, B18). We presume that this is because of short stay patients 
(LOS ranged from 1.96-2.69) and low direct costs (ranged from 394.95€ to 476.91 €).  We 
observed that the more complex procedures cause higher direct costs (E12), which is 
consistent with Davenport et. al. (2005) findings. That’s why the total costs estimated with 
Marginal Mark-up method are higher than estimated with LOS method.  It is also consistent 
with Dindo et al. (2004) study which demonstrated that the complexity of surgery is 
significantly correlated with length of hospital stay and the occurrence of complications. In 
addition, Wang et al. (2009) proved that there is a correlation between the occurrence of 
complications and the level of direct costs. For most surgical procedures (M15, B19, E27, 
B18) the mean indirect costs is higher for the CVU method than for LOS or Marginal Mark-
up method. For all the medical procedures (N09, N07D, A48, N03) the mean of indirect costs 
calculated by CVU method is in the range between Marginal Mark-up and LOS method. 
Carreras et al. (2011) reported that the selection of an overhead allocation methodology does 
not produce significant distortion of results. Our study didn’t confirm this finding, indeed the 
CVU method is significantly different from LOS method and Marginal Mark-up method. We 
revealed that in all DRG but one (N09) the CH for CVU is higher than for LOS or Marginal 
Mark-up method. The positive influence of the cost allocation method on coefficient of 
homogeneity was also described by Vogl (2013). We believe that this method reflects most 
closely actual resource consumption and is a good alternative for LOS and Marginal Mark-up 
method.  
 
5.2. Implications 
Although specific costs, as well as predetermined cost allocation factors may be unique at 
each hospital, the applicability of this method is generalizable. The CVU method is a window 
into understanding and quantifying the variation in resource use in hospitals. It provides a 
reasonable compromise between accuracy and ease of implementation in estimating patient 
level costs.  
Cost differences between the hospital services are determined by costing methodology and 
actual performacne of the hospital (Drummond et al., 2005). Because the level of accuracy of 
cost estimates is determined by both, the identification and valuation of cost copmponenets, 
the results of CVU method will be determined by approach to resource used employment for a 
patient in hospital. The CVU method may be a strong alternative to traditional indirect cost 
allocation methods in hospitals that are likely to show wide cost variation between patients as 
the consequences of their health condition. As the reliability of cost estimates is determined 
by the share of overheads in total hospital costs (Tan, Rutten et al., 2009), we conclude that 
the use of CVU method should be especially considered for hospitals with a large cost 
component of labour and overheads. Latimer et al. (1995) emphasize that a reasonable 
balance must be struck between the resources used to allocate direct costs and those used to 
allocate indirect costs. This is because the higher level of indirect costs, the greater 
significance of the indirect cost allocation method on costs estimates. The results of CVU 
method and its’ relations to Length of Stay and Marginal Mark-up methods may produce 
different results in different hospitals, depending on the cost structure. Hovewer, to determine 
to what extent the level of direct costs influance on (minimise or maximise) the role of 
indirect cost allocation method, future studies are needed. 
CVU method can also be adopted in examining the average cost per DRG. By integrating 
data describing patient characteristics, health condition and hospital treatment with costs, the 
hospital managers and also clinicians can begin to understand where there is variation in 
treatment for individual medical conditions  
For both research and clinical applications, it is important to test the roboustness of the 
results. For example, costs calculated through the CVU method can be used in the cost portion 
of a cost effectiveness or cost benefit analysis. A sensitivity analysis can then be performed to 
determine how the outcomes, and therefore decisions, might vary when certain parameters, 
like the percentage of hospital complications, are changed. CVU can provide the type of 
evidence-based outcomes that will assists the hospital services in creating best practice 
application for use in setting acceptable standards of care. When the CVU method is 
combined with clinical pathways, managers and clinicians can focus on improving quality of 
healthcare and reducing costs. For example using the CVU method managers can assess the 
impact of adverse events on the hospital costs in terms of incurring additional expenses or 
preventability. The importance of CVU method may increase particulary in those areas where 
pricing is based on diagnosis related groups, as the effective operation of this concept depends 
largely on the proper cost accounting system, which ensures the cost homogeneity of 
individual groups (Feyrer et al., 2005; Raulinajtys-Grzybek, 2014).  
In this paper, we focused on hospital-based treatment approach. The CVU method can be 
also used in Emergency Department (ED), as the need for transparent method for allocating 
EDs’ overhead costs, has been claimed by many authors (April & Murray, 2017). However, 
patient-related parameters used to build a Clinical Value Unit scale in ED may differ. 
 
5.3. Limitations of the CVU method 
Clinical Value Unit method has limitations. It should not be viewed as a method to fix 
hospital costs, but rather as a tool to help managers and clinicians to measure patient costs and 
refare them to patient characteristics, health condition on admission and hospital treatment 
process. Implementing CVU method requires an initial effort to collect medical records and 
integrate them with accounting system. Some of the medical information may already be in IT 
system and need just to be linked to patient records, others will need to be covered by the IT 
system. However, the advantage of CVU method that one can use data available in the 
hospital information system. But it must be kept in mind that the more data on the input, the 
more accurate results. 
 
6. Limitations of the study 
We considered age, LOS, gender, type of admission, reason for discharge, Intensive Care 
Union (ICU) stay and the number of departments that the patient was treated on, as the 
possible factors that may influence the hospital costs. Other variables presented in the 
conceptual framework were not covered in the analysis because of limited data within the 
hospital information system. 
7. Conclusions 
The causal relationship between resource use and treatment is limited when standard 
principles of calculating patient costs are used. This is because indirect costs are generally 
calculated on the assumption that the duration of hospitalization is the only factor that drives 
resource use. In fact not all hospital days are economically equivalent, and length of stay is 
not the only factor influencing costs. The developed CVU method largely resolves this 
problem by introducing patient-related parameters, the patient’s health condition on admission 
and hospital course in the process of calculating treatment costs. The costing study 
demonstrates that the selection of an overhead allocation methodology produces significantly 
different results. Although LOS and Marginal Mark-up allocation methods are acceptable 
from an accounting perspective, developed method reports more accurate costs than 
conventional systems, provides more detailed information related to patients and is more 
convenient and not as complex as ABC. Popular overhead allocation methods like LOS 
method or Marginal Mark-up method can overestimate or under estimate the proportion of 
indirect costs. We conclude that CVU method is a more precise and reliable alternative to the 
Length of Stay and Marginal Mark-up allocation method.  
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Tab. 1. Estimation of Clinical Value Units (CVU)   
Parameters 
describing the 
patient and hospital 
treatment 
Correlates Explaining variables Variable 
Beta 
coefficient 
Demographic and 
social data 
Gender 
Female 
Male 
X1 β1 
Age (years) X2 β2 
Substance abuse 
Smoking 
Alcohol 
Other 
X3 
X4 
X5 
β3 
β4 
β5 
Family history 
Patient lives with family 
Patient lives alone 
X6 
X7 
β6 
Living 
conditions 
Welfare recipient 
Homeless 
X8 
X9 
β7 
Professional 
activity 
Professionally active 
Unemployed 
X10 
X11 
β8 
Health condition on 
admission 
Type of 
admission  
Planned admission 
Emergency admission – 
ER 
Urgent admission – 
Medical Emergency Unit 
Inter-hospital transfer 
X12 β12 
Functional 
independence 
on admission  
Independent 
Moderately independent 
Dependent 
X13 β13 
Comorbidities X14 β14 
Hospital treatment 
Undesirable 
events 
Hospital-acquired 
infections 
Surgical complications 
Bed sores 
Other 
X15 
X16 
X17 
X18  
β15 
Length of stay (days) X19 β16 
Diet 
Standard diet 
Nutritional therapy 
X20 β17 
Enteral nutrition 
Parenteral nutrition 
X21 β18 
Inter-ward transfer (number of wards) X22 β19 
Reason of 
discharge  
End of diagnostic and 
therapeutic process 
Follow-up outpatient 
treatment 
Inter-hospital transfer 
Discharge against medical 
advice 
Death 
X23 Β20 
SUM CVUs 
 
  
Tab. 2 Nine high volume DRGs in hospital in 2016 
DRG Description 
Number 
of cases 
Length 
of stay 
Diagnosis 
N09 
Severe pregnancy pathology with delivery - extended 
diagnostics, comprehensive treatment > 10 days 
645 13.24 Medical 
M15 Small surgery on the upper part of the reproductive system 629 1.06 Surgical 
B19 
Removal of unspecified cataract with simultaneous implantation 
of the lens 
619 1.96 Surgical 
E27 Coronary angiography and other invasive procedures 476 2.69 Surgical 
E12 Acute Coronary Syndromes - complex invasive treatment 438 4.48 Surgical 
B18 
Removal of cataract complicated with simultaneous implantation 
of the lens 
396 2.29 Surgical 
N07D 
Severe pregnancy pathology - extended diagnostics, 
comprehensive treatment> 4 days  
346 9.49 Medical 
A48 Comprehensive stroke treatment> 7 days in stroke department 292 10.94 Medical 
N03 Pathology of pregnancy or fetal delivery> 5 days 185 37.96 Medical 
DRG – Diagnosis Related Groups 
 
  
Tab. 3 Multivariate ligistic regression model to define Clinical Value Units for the CVU method  
Variables β - coefficient OR IC p-Value 
Age 0.0646 1,098 (0,514-2,156) <0.001 
Male 0.1109 1,157 (0,719-2,475) <0.001 
LOS 0.3535 2,513 (1,812-5,293) <0.001 
ICU stay 0.1836 1,365 (1,015-3,193) <0.001 
number of 
departments>1 
0.0305 1,012 (0,364-1,571) 
<0.004 
R2 = 0.3861 
OR – Odds Ratio; IC – Interval Confidence  
* p-Value – statistical significance for multivariate logistic regression  analysis. 
 
  
Tab. 4 Clinical Value Units for patients within DRG  
 
CVU- Clinical Value Unit; DRG – Diagnosis Related Groups 
DRG 
CVU 
Mean (sd) Total 
N09 9.39 (2.34) 4429.38 
M15 4.88 (1.56) 1666.62 
B19 5.12 (1.67) 2832.45 
E27 5.45 (1.99) 2693.41 
E12 6.27 (2.06) 3181.52 
B18 5.52 (1.68) 2764.04 
N07D 8.03 (2.58) 3404.75 
A48 9.07 (2.84) 5043.79 
N03 19.01 (3.97) 10903.54 
Tab. 5 Cost estimates for the Clinical Value Unit (CVU), Length of Stay (LOS) and Marginal Mark-up method 
 
DRG 
Direct costs 
Mean (SD) 
[€] 
Indirect costs  
Mean (SD) [€] 
Total costs 
Mean (SD) [€] 
Mean difference compared to 
CVU [€] 
p-value 
CVU LOS 
Marginal 
Mark-up 
CVU LOS 
Marginal 
mark-up 
LOS 
Marginal 
mark-up 
N09 
779.27 
(786.45) 
1,111.80 
(419.97) 
1,971.76 
(945.28) 
626.12 
(631.88) 
1,891.08  
(942.03) 
2,751.04 
(1311.24) 
1,405.39 
(1418.34) 
859.96 
(528.55) 
-485.68 
(708.02) 
=0.001* 
=0.001** 
M15 
78.85 
(97.11) 
418.33 
(106.17) 
158.15 
(44.70) 
60.94 
(78.02) 
494.18 
(151.74) 
234.01 
(124.25) 
136.80 
(175.13) 
-260.17 
(107.89) 
-357.38 
(124.48) 
=0.001* 
=0.001** 
B19 
394.95  
(89.72) 
710.96  
(94.39) 
293.27  
(150.17) 
317.33 
(72.08) 
1,105.91 
(144.69) 
688.22 
(198.66) 
712.27 
(161.80) 
-417.69 
(102.57) 
-393.63 
(104.45) 
=0.001* 
=0.001** 
E27 
476.91 
(401.78) 
676.06 
(100.96) 
400.46  
(150.63) 
383.18 
(322.81) 
1,152.97 
(419.39) 
877.38 
(436.04) 
860.10 
(724.59) 
-275.60 
(107.31) 
-292.87 
(333.12) 
=0.001* 
=0.001** 
E12 
2,023.03 
(748.66) 
798.58 
(168.62) 
667.76  
(315.50) 
1,625.44 
(601.52) 
2,821.62 
(762.30) 
2,690.80 
(830.72) 
3,898.47 
(1350.18) 
-130.82 
(186.87) 
826.86 
(629.72) 
=0.001* 
=0.001** 
B18 
404.73 
(106.97) 
693.79 
(155.31) 
341.46 
(248.52) 
325.19  
(85.95) 
1,098.52 
(214.05) 
746.20 
(302.64) 
729.92 
(192.92) 
-352.32 
(154.57) 
-368.60 
(152.55) 
=0.001* 
=0.001** 
N07D 
320.64 
(685.02) 
854.61 
(377.08) 
1,413.46 
(844.50) 
257.63 
(550.39) 
1,175.25 
(808.93) 
1,743.11 
(1130.43) 
578.27 
(1235.41) 
567.86 
(321.50) 
-596.98  
(426.48) 
=0.001* 
=0.001** 
A48 
525.89 
(424.20) 
1,266.02 
(246.51) 
1,628.95 
(504.89) 
422.54 
(340.83) 
1,791.91 
(545.74) 
2,154.84 
(757.54) 
948.42  
(765.04) 
362.93 
(211.80) 
-843.49 
(219.30) 
=0.001* 
=0.001** 
N03 
1,135.75 
(796.22) 
2,736.85 
(1509.67) 
5,653.38 
(3414.14) 
912.54 
(639.74) 
3,872.61 
(2020.09) 
6,789.13 
(3865.99) 
2,048.30 
(1435.97) 
2,916.52 
(1845.90) 
-1,824.31 
(-584.12) 
=0.001* 
=0.001** 
 
*Wilcoxon signed ranks Z-test CVU to LOS; **Wilcoxon signed ranks Z-test CVU to marginal mark-up; CVU- Clinical Value Unit; DRG – Diagnosis Related Groups; LOS – 
Length of Stay 
Tab. 6 Coefficient of homogeneity of costs for CVU, LOS and Marginal Mark-up method. 
DRG 
CH [%] 
CVU LOS Marginal Mark-up 
N09 0.6675 0.6772 0.4977 
M15 0.7651 0.6532 0.4386 
B19 0.8843 0.7760 0.8149 
E27 0.7333 0.6680 0.5428 
E12 0.7873 0.7641 0.7299 
B18 0.8369 0.7114 0.7910 
N07D 0.6938 0.6259 0.3189 
A48 0.8370 0.7634 0.5535 
N03 0.6444 0.6235 0.5879 
CH – coefficient of homogeneity; CVU- Clinical Value Unit, DRG – Diagnosis Related Groups; LOS – Length 
of Stay 
 
 
